Charlotte Gurr / The Pharmaceutical Journal
The latest edition of Medicines, Ethics and Practice (MEP) includes new sections on gender incongruence and dysphoria, and pharmacy services at a distance, which are aimed to show “the growing complexity of pharmacy practice”, the Royal Pharmaceutical Society (RPS) has said.
This iteration of MEP, published on 21 July 2025, marks the 48th edition of the professional guide for pharmacists.
The new material on gender incongruence and dysphoria includes guidance aimed to help pharmacists decide whether a supply of gonadotrophin-releasing hormone analogues for children and young people would be appropriate or not. It also includes information to help pharmacists signpost to support provided by other organisations.
The MEP sets out guidance on pharmacy services at a distance — including online — that provides signposting to, and information on, the General Pharmaceutical Council’s (GPhC) guidance for registered pharmacies providing these services.
Existing sections of the MEP have also been updated, including information about the RPS’s position statement on facilitated self-selection of Pharmacy (P) medicines, guidance on new legislation for original pack dispensing, and guidance around emergency supply at the request of a patient, to help pharmacists ensure duplicate supplies of a medicine are not provided.
Rakhee Amin, senior professional standards pharmacist at the RPS and editor of MEP, said: “This edition reflects the continuing evolution of pharmacy practice. We’ve worked closely with colleagues and expert contributors to ensure that MEP remains a valuable, relevant and trusted resource.
“We encourage all members to explore the easy-to-use digital MEP for up-to-date information wherever you practise.”
The digital MEP is free to access for all RPS members, and all foundation trainee members receive a free print copy.
